Glad to share a glimpse of my speech to the audience of 2019 Pharma Synergy Conference in Berlin. A pleasure being part of an excellent panel of speakers discussing trends in the #Biosimilars space. #pharmasynergy#Pharma
https://t.co/mdSJx8zh4V
Helsinn Group announces agreement to acquire worldwide rights to Valchlor/Ledaga, an approved and marketed alkylating agent for topical treatment of mycosis fungoides type cutaneous T-cell lymphoma
https://t.co/orgUxQ7tKi
Is it really one single country? Blu is right wing populism, yellow is anti-establishment populism... picture of a country in need of someone who knows what he is doing and instead goes berserk...
Binimetinib combined with encorafenib resulted in an improvement to median overall survival by 33.6 months in BRAF-mutant melanoma. Sorry Roche... https://t.co/Dgzf5tpbiB